论文部分内容阅读
目的探讨甲状腺髓样癌合并乳头状癌的临床特征。方法回顾性分析2009年1月至2016年3月华西医院甲状腺外科初治的13例甲状腺髓样癌合并乳头状癌(合并组)和101例甲状腺髓样癌病人(甲状腺髓样癌组)临床资料。结果合并组与甲状腺髓样癌组病人的年龄[(45.4±12.5)岁vs.(45.7±14.2)岁]、性别等基础资料以及病灶[最大径(27.3±17.7)mm vs.(25.4±14.8)mm]、淋巴结转移等病理特征差异均无统计学意义。结论甲状腺髓样癌合并乳头状癌与单纯甲状腺髓样癌的侵袭性和预后无明显不同。
Objective To investigate the clinical features of medullary thyroid carcinoma with papillary carcinoma. Methods Thirteen patients with thyroid medullary carcinoma with papillary carcinoma (merger group) and 101 patients with medullary thyroid carcinoma (with medullary thyroid carcinoma group) were retrospectively analyzed from January 2009 to March 2016 in the Department of Thyroid Surgery, West China Hospital. data. Results The age of the patients in the combined group and the medullary thyroid carcinoma group [(45.4 ± 12.5) years vs. (45.7 ± 14.2 years)], gender and other underlying data, as well as the size of the lesions [27.3 ± 17.7 mm vs 25.4 ± 14.8 ) mm], lymph node metastasis and other pathological differences were not statistically significant. Conclusions There is no significant difference in the invasiveness and prognosis of medullary thyroid carcinoma with papillary carcinoma and medullary thyroid carcinoma alone.